1.
Med rev
; 11(12)2003.
Artículo
en Inglés
| CUMED
| ID: cum-31531
RESUMEN
A preliminary report was presented on results of pre-hospitalization use of Cuban recombinant streptokinase in patients with acute myocardial infarction in seven provinces, where emergency care systems have been integrated into primary care models. 249 patients received pre-hospitalization thrombolysis in these provinces form late 1997 to May 1999. Of these, four died (1.6 por ciento), and 98.4 por ciento survived. Lethality for patients who received pre-hospitalization thrombolytic treatment was found to be lower (3.45) than that calculated for patients treated in a hospital setting (10.36). Of all the patients who received pre-hospitalization thrombolysis, 69 por ciento were treated within 90 minutes of the onset of symptoms(AU)